Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
9.92 USD | +4.64% | +7.36% | +207.12% |
May. 15 | Needham Adjusts Price Target on Arcutis Biotherapeutics to $18 From $16, Maintains Buy Rating | MT |
May. 15 | Sector Update: Health Care Stocks Rise Pre-Bell Wednesday | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+207.12% | 1.15B | |
+9.99% | 115B | |
+12.01% | 106B | |
-3.07% | 24.69B | |
-0.73% | 21.97B | |
-4.41% | 19.27B | |
-6.90% | 17.56B | |
-39.36% | 17.32B | |
+5.82% | 14.03B | |
+33.05% | 12.13B |
- Stock Market
- Equities
- ARQT Stock
- News Arcutis Biotherapeutics, Inc.
- Earnings Flash (ARQT) ARCUTIS BIOTHERAPEUTICS Posts Q4 Revenue $13.5M, vs. Street Est of $11.4M